SCNN1A and acute respiratory distress syndrome: Studies have shown that inflammatory mediators downregulate ENaC-α and AQP-1 protein expression and impede pulmonary edema fluid removal, which in turn increases pulmonary vascular permeability in patients with ARDS [21].